We are live on ! Find out more
EVGN icon

Evogene

15 hedge funds and large institutions have $65.1M invested in Evogene in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.34% more ownership

Funds ownership: 1.64%1.98% (+0.34%)

0% more funds holding

Funds holding: 1515 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

3% less capital invested

Capital invested by funds: $66.8M → $65.1M (-$1.72M)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

Holders
15
Holders Change
Holders Change %
0%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change

EVGN Hedge Fund Activity: Q3 2014 in Review

15 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q3 2014, worth a combined $65.1M — down 2.6% from $66.8M a quarter earlier.

Fund positioning in EVGN was balanced in Q3 2014: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 5 trimmed.

The largest buyer was Waddell & Reed Financial, adding an estimated $9.97M. The largest seller was Goldman Sachs, cutting an estimated $2.47M.

  • 15 institutional investors held Evogene (EVGN) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $65.1M of Evogene stock for Q3 2014, down 2.6% quarter-over-quarter.
  • 2 funds opened new Evogene positions in Q3 2014 and 2 closed out, a net change of 0 holders.
  • The largest Evogene buyer in Q3 2014 was Waddell & Reed Financial, an estimated $9.97M added.
  • The largest Evogene seller in Q3 2014 was Goldman Sachs, an estimated $2.47M sold.

Based on aggregated 13F filings for Q3 2014.